A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
From - Diagnostic Testing & Emerging Technologies
Only one in six baby boomers report having been tested for hepatitis C virus (HCV)< despite recommendations for…
From - Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
From - Diagnostic Testing & Emerging Technologies
Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity&…
From - Diagnostic Testing & Emerging Technologies
Samples collected from a mouth rinse can detect human papillomavirus (HPV) DNA. These easily collected samples might provide important monitoring information for…
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration-cleared POC Afinion HbA1c Dx test (Alere Technologies a subsidiary of Abbott Laboratories) is accurate and…
From - Diagnostic Testing & Emerging Technologies
To control the spread of HIV in the United States, HIV infection must be diagnosed early and persons with HIV infection must be…
From - Diagnostic Testing & Emerging Technologies
Serial measurement of high-sensitivity C-reactive protein (hsCRP) levels following acute coronary syndrome may help…